Literature DB >> 22710749

Colombia at the centre of preclinical AD research.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22710749     DOI： 10.1016/S1474-4422(12)70144-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  8 in total

Review 1.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

2.  Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease.

Authors:  James A R Nicoll; George R Buckland; Charlotte H Harrison; Anton Page; Scott Harris; Seth Love; James W Neal; Clive Holmes; Delphine Boche
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

3.  Passive immunotherapy for Alzheimer's disease: what have we learned, and where are we headed?

Authors:  P S Aisen; B Vellas
Journal:  J Nutr Health Aging       Date:  2013-01       Impact factor: 4.075

4.  Primary or secondary prevention for AD: who cares?

Authors:  Giovanni B Frisoni; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2012-06-15       Impact factor: 44.182

5.  Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in Puerto Rican Hispanics with dementia.

Authors:  Steven E Arnold; Irving E Vega; Jason H Karlawish; David A Wolk; Jessica Nunez; Mirna Negron; Sharon X Xie; Li-San Wang; Jacob G Dubroff; Elisabeth McCarty-Wood; John Q Trojanowski; Vivianna Van Deerlin
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  The presenilin 1 p.Gly206Ala mutation is a frequent cause of early-onset Alzheimer's disease in Hispanics in Florida.

Authors:  Thomas A Ravenscroft; Cyril Pottier; Melissa E Murray; Matt Baker; Elizabeth Christopher; Denise Levitch; Patricia H Brown; Warren Barker; Ranjan Duara; Maria Greig-Custo; Ana Betancourt; Mara English; Xiaoyan Sun; Nilüfer Ertekin-Taner; Neill R Graff-Radford; Dennis W Dickson; Rosa Rademakers
Journal:  Am J Neurodegener Dis       Date:  2016-03-01

Review 7.  Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.

Authors:  Gloria Patricia Cardona-Gómez; Francisco Lopera
Journal:  Front Aging Neurosci       Date:  2016-12-20       Impact factor: 5.750

8.  Women with the Alzheimer's risk marker ApoE4 lose Aβ-specific CD4⁺ T cells 10-20 years before men.

Authors:  A N Begum; C Cunha; H Sidhu; T Alkam; J Scolnick; E R Rosario; D W Ethell
Journal:  Transl Psychiatry       Date:  2014-07-29       Impact factor: 6.222
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.